Program Chair Summary: The Current and Future Roadmap to Optimizing Glycemic Control in T2D with Physiologic, Long-Acting Basal Insulin The Evidence - Guideline, and Mechanistic Rationale for Long-Acting, Physiologic Basal Insulin
Registration
Program Chair Summary: The Current and Future Roadmap to Optimizing Glycemic Control in T2D with Physiologic, Long-Acting Basal Insulin The Evidence - Guideline, and Mechanistic Rationale for Long-Acting, Physiologic Basal Insulin
Would you like to continue where you left off?
Program Chair Summary: The Current and Future Roadmap to Optimizing Glycemic Control in T2D with Physiologic, Long-Acting Basal Insulin The Evidence - Guideline, and Mechanistic Rationale for Long-Acting, Physiologic Basal Insulin
